Clinical review: Probiotics in critical care
Open Access
- 5 November 2012
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 16 (6) , 237-12
Abstract
Patients in ICUs represent a relatively small subgroup of hospitalised patients, but they account for approximately 25% of all hospital infections. Approximately 30% of ICU patients suffer from infection as a complication of critical illness, which increases the length of ICU stay, morbidity, mortality and cost. Gram-negative bacteria are the predominant cause of ICU-related infections and with the rise in multidrug-resistant strains we should focus our attention on nonantibiotic strategies in the prevention and treatment of nosocomial infections. Probiotics have been proposed as one option in this quest; however, mechanisms of action in the critically ill population require further investigation. Some of the beneficial effects appear to be associated with improvement in gastrointestinal barrier function, restoration of normal intestinal permeability and motility, modification of the balance of intestinal microbiota and immunomodulation. However, the information we have to date on the use of probiotics in the critical care setting is difficult to interpret due to small sample sizes, differences in ICU populations, the variety of probiotic combinations studied and differences in administration techniques. In this review we shall examine the use of probiotics in the critical care setting, look at some of the proposed mechanisms of action and discuss their potential benefits and drawbacks.Keywords
This publication has 98 references indexed in Scilit:
- Probiotic Prophylaxis of Ventilator-associated Pneumonia: A Blinded, Randomized, Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Altered Gut Flora Are Associated with Septic Complications and Death in Critically Ill Patients with Systemic Inflammatory Response SyndromeDigestive Diseases and Sciences, 2010
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Probiotics versus antibiotic decontamination of the digestive tract: infection and mortalityIntensive Care Medicine, 2010
- A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti‐inflammatory effects in lipopolysaccharide‐induced sepsis in miceBritish Journal of Pharmacology, 2009
- Probiotics Affect Virulence-Related Gene Expression in Escherichia coli O157:H7Applied and Environmental Microbiology, 2007
- Effect of Enteral Nutrition and Synbiotics on Bacterial Infection Rates After Pylorus-preserving PancreatoduodenectomyAnnals of Surgery, 2007
- Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118Proceedings of the National Academy of Sciences, 2007
- Perioperative Synbiotic Treatment to Prevent Postoperative Infectious Complications in Biliary Cancer SurgeryAnnals of Surgery, 2006
- Interleukin-12 is involved in the enhancement of human natural killer cell activity byLactobacillus caseiShirotaClinical and Experimental Immunology, 2006